Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Persistent Pulmonary Hypertension of the Newborn clinical trials
1 of 2 indexed Persistent Pulmonary Hypertension of the Newborn trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Persistent Pulmonary Hypertension of the Newborn: 2 US clinical trials tracked, 1 recruiting.
Persistent Pulmonary Hypertension of the Newborn is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is University of California, Davis, running 1 of these trials.
Enrollment posture brief
Registry condition persistent-pulmonary-hypertension-of-the-newborn
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Persistent Pulmonary Hypertension of the Newborn lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Persistent Pulmonary Hypertension of the Newborn on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Persistent Pulmonary Hypertension of the Newborn is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Medical College of Wisconsin
NCT00710177
Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension
University of California, Davis
NCT04938167
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Persistent Pulmonary Hypertension of the Newborn records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Persistent Pulmonary Hypertension of the Newborn trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Persistent Pulmonary Hypertension of the Newborn page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Persistent Pulmonary Hypertension of the Newborn trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, Davis sponsors the most Persistent Pulmonary Hypertension of the Newborn trials on record, review their full trial history before evaluating a specific study. See University of California, Davis's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Persistent Pulmonary Hypertension of the Newborn condition card totals 2 registered trials; most-linked intervention 95% - 99% SpO2 target; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.